Efficacy and safety of Tafolecimab in Chinese patients with type 2 diabetes and hypercholesterolemia: a post-hoc analysis of pooled data from three phase 3 trials by Litong Qi, Hua Shen, Meng Chai, Beijian Chen, Yongming He, Xiaoxia Shi, Qiufang Lian, Wang Zhao, Yanling Qu, Lei Qian, Jianwei Zhang, Haoyu Li, Yujie Zhou, Yong Huo

Get full text